All About Testicular Cancer
•
1 like•1,901 views
A common stereotype of manhood is the resistance to professional assistance. This includes stopping to ask for directions. Hiring someone to fix the kitchen sink. And most dangerous of all, the "no need" attitude towards visits to the doctor. This is why the BTB Foundation has partnered with the Testicular Cancer Society to help spread awareness about the risks and symptoms of testicular cancer. Even with one of the highest survival rates among cancerous diseases, an astonishing 390 men die annually from this illness. One of the biggest contributors to this statistic is the lack of education. When men know the risks and get to their doctor when symptoms surface, there is a 96% survival rate. For all those men who have been taken by this disease, share the following information about testicular cancer with every man you know. It's time to save a life. Learn more about the BTB Foundation here http://www.btbsunglasses.com/btb-foundation-s/21.htm
Report
Share
Report
Share
Download to read offline
Recommended
Testicular cancer for public awareness by Dr Rubz
A presentation prepared for Charity Dinner with Fun Charity. All the profits of the event will go to FReHA (a NGO which supports women's and reproductive health.)
Testicular Cancer
Testicular cancer is one of the most curable cancers, with a 5-year survival rate now over 95% due to improved treatments. It typically affects young men between puberty and age 35. Successful treatment involves radical orchiectomy, chemotherapy, and sometimes radiation or retroperitoneal lymph node dissection. A radical orchiectomy surgically removes the testicle and is the standard treatment for suspected testicular cancer based on findings such as a painless testicular mass. While scrotal violations during surgery were once thought to worsen prognosis, evidence now suggests this is not the case if there is no tumor spillage.
Testicular tumors
1. Testicular cancer represents 1% of cancers in men and is classified as germ cell tumors (95%), gonadal stromal tumors, or secondary tumors from other cancers.
2. Germ cell tumors are further divided into seminomas and non-seminomas including teratomas, embryonal cell carcinomas, and choriocarcinomas.
3. Ultrasound is useful for imaging testicular tumors and can show characteristics such as hypoechogenicity, heterogeneity, cysts, and calcifications that help differentiate tumor types.
Testicular tumors
The document discusses testicular tumors, providing details on:
1) Germ cell tumors (seminomas and nonseminomas) account for 95% of testicular tumors and can spread rapidly.
2) Sex cord-stromal tumors include Leydig cell and Sertoli cell tumors.
3) Risk factors for germ cell tumors include cryptorchidism, pesticide exposure, and genetic factors. Tumor markers like HCG, AFP, and LDH help diagnose and monitor these cancers.
Testicular Cancer
A 23-year-old Mexican American male presented with a right testicular mass and lesions in his lungs and retroperitoneum. A biopsy revealed nonseminomatous germ cell tumor of the right testis that had metastasized. He underwent chemotherapy with bleomycin, etoposide, and cisplatin but experienced complications including febrile neutropenia and pulmonary embolism. His treatment plan was adjusted based on his complications and response to therapy.
Sumit testicular tumors
This document provides an overview of testicular cancer, including:
1. Testicular cancer most commonly affects men aged 20-40 and is the most common cancer in that age group. It has very good survival rates due to effective diagnostic techniques, tumor markers, and multimodal treatments.
2. Risk factors include cryptorchidism, Klinefelter syndrome, trauma, and genetic factors. Cryptorchidism increases risk by 14-48 times.
3. Types include seminomas, embryonal carcinomas, teratomas, and others. Seminomas and non-seminomas are treated differently.
4. Diagnosis involves physical exam, ultrasound, tumor markers like AFP and H
Testicular Cancer
This document discusses testicular cancer, including its epidemiology, classification, investigations, and treatment. It notes that testicular cancer is most common in young men aged 15-35 years old and has a high cure rate. The main types are seminomas and non-seminomas. Staging involves tumor markers, ultrasound, CT scan, and radical orchiectomy. For high-risk patients, retroperitoneal lymph node dissection may be used. Modern treatment is multimodal and based on the patterns of metastasis, with chemotherapy and nerve-sparing surgery improving outcomes.
Testicular cancer TCA
Testicular cancer occurs when abnormal cells in the testicles divide and grow uncontrolled. It is highly treatable and usually curable, with a cure rate of over 90% across all ages. The document discusses risk factors like age, undescended testicles, family history, and certain infections. It also describes the types of testicular cancers, signs and symptoms, diagnostic tests, and treatments which typically involve surgical removal of the testicle and lymph nodes, as well as potential chemotherapy or radiation therapy. Nursing care focuses on monitoring the patient during and after treatment and addressing issues related to body image, sexuality, and the importance of self-examination.
Recommended
Testicular cancer for public awareness by Dr Rubz
A presentation prepared for Charity Dinner with Fun Charity. All the profits of the event will go to FReHA (a NGO which supports women's and reproductive health.)
Testicular Cancer
Testicular cancer is one of the most curable cancers, with a 5-year survival rate now over 95% due to improved treatments. It typically affects young men between puberty and age 35. Successful treatment involves radical orchiectomy, chemotherapy, and sometimes radiation or retroperitoneal lymph node dissection. A radical orchiectomy surgically removes the testicle and is the standard treatment for suspected testicular cancer based on findings such as a painless testicular mass. While scrotal violations during surgery were once thought to worsen prognosis, evidence now suggests this is not the case if there is no tumor spillage.
Testicular tumors
1. Testicular cancer represents 1% of cancers in men and is classified as germ cell tumors (95%), gonadal stromal tumors, or secondary tumors from other cancers.
2. Germ cell tumors are further divided into seminomas and non-seminomas including teratomas, embryonal cell carcinomas, and choriocarcinomas.
3. Ultrasound is useful for imaging testicular tumors and can show characteristics such as hypoechogenicity, heterogeneity, cysts, and calcifications that help differentiate tumor types.
Testicular tumors
The document discusses testicular tumors, providing details on:
1) Germ cell tumors (seminomas and nonseminomas) account for 95% of testicular tumors and can spread rapidly.
2) Sex cord-stromal tumors include Leydig cell and Sertoli cell tumors.
3) Risk factors for germ cell tumors include cryptorchidism, pesticide exposure, and genetic factors. Tumor markers like HCG, AFP, and LDH help diagnose and monitor these cancers.
Testicular Cancer
A 23-year-old Mexican American male presented with a right testicular mass and lesions in his lungs and retroperitoneum. A biopsy revealed nonseminomatous germ cell tumor of the right testis that had metastasized. He underwent chemotherapy with bleomycin, etoposide, and cisplatin but experienced complications including febrile neutropenia and pulmonary embolism. His treatment plan was adjusted based on his complications and response to therapy.
Sumit testicular tumors
This document provides an overview of testicular cancer, including:
1. Testicular cancer most commonly affects men aged 20-40 and is the most common cancer in that age group. It has very good survival rates due to effective diagnostic techniques, tumor markers, and multimodal treatments.
2. Risk factors include cryptorchidism, Klinefelter syndrome, trauma, and genetic factors. Cryptorchidism increases risk by 14-48 times.
3. Types include seminomas, embryonal carcinomas, teratomas, and others. Seminomas and non-seminomas are treated differently.
4. Diagnosis involves physical exam, ultrasound, tumor markers like AFP and H
Testicular Cancer
This document discusses testicular cancer, including its epidemiology, classification, investigations, and treatment. It notes that testicular cancer is most common in young men aged 15-35 years old and has a high cure rate. The main types are seminomas and non-seminomas. Staging involves tumor markers, ultrasound, CT scan, and radical orchiectomy. For high-risk patients, retroperitoneal lymph node dissection may be used. Modern treatment is multimodal and based on the patterns of metastasis, with chemotherapy and nerve-sparing surgery improving outcomes.
Testicular cancer TCA
Testicular cancer occurs when abnormal cells in the testicles divide and grow uncontrolled. It is highly treatable and usually curable, with a cure rate of over 90% across all ages. The document discusses risk factors like age, undescended testicles, family history, and certain infections. It also describes the types of testicular cancers, signs and symptoms, diagnostic tests, and treatments which typically involve surgical removal of the testicle and lymph nodes, as well as potential chemotherapy or radiation therapy. Nursing care focuses on monitoring the patient during and after treatment and addressing issues related to body image, sexuality, and the importance of self-examination.
Testicular cancer
The document discusses testicular cancer and provides details on its epidemiology, classification, staging, diagnosis, and disease management. Some key points:
- Testicular cancer peaks in the third decade for non-seminoma and fourth decade for seminoma. Risk factors include cryptorchidism, family history, and subfertility.
- Germ cell tumors are divided into seminoma and non-seminomatous tumors including embryonal carcinoma, teratoma, and choriocarcinoma.
- Stage I disease accounts for 75-80% of seminoma and 55% of non-seminoma cases at diagnosis. Serum tumor markers and imaging help determine diagnosis and staging.
Testicular carcinoma
This document provides a summary of testicular carcinoma and germ cell tumors. It discusses the classification, spread, clinical features, investigations, and staging of testicular tumors. The majority are germ cell tumors, with seminomas and non-seminomatous germ cell tumors being the most common. Metastatic sites vary between seminomas and non-seminomas. Prognostic factors are important for determining treatment. Screening is recommended for high risk groups to detect tumors early.
Testicular tumors - ramu
This document discusses testicular tumors. It notes that testicular cancer is rare but the most common solid malignancy in young men aged 15-35. The main types of testicular tumors are germ cell tumors (such as seminoma, embryonal carcinoma, teratoma, and choriocarcinoma) and non-germ cell tumors. Risk factors include cryptorchidism, family history, and testicular cancer history. Diagnostic tests include scrotal ultrasound and serum tumor markers. Radical inguinal orchiectomy is the standard treatment for removal of the testis.
Carcinoma penis
This document discusses carcinomas and precancerous conditions of the penis. It describes several precancerous conditions that have potential to develop into penile cancer, including penile intraepithelial neoplasia, balanitis xerotica obliterans, and Buschke-Lowenstein tumour. Squamous cell carcinoma is the most common type of penile cancer. Risk factors include age, pre-existing lesions, lack of circumcision, HPV infection, and smoking. Treatment involves surgery for the primary tumor as well as lymphadenectomy for lymph node involvement.
Testicular cancer
This document discusses testicular cancer, including:
- 95% of testicular cancers are germ cell tumors known as seminomas or non-seminomas.
- Risk factors include undescended testes, male infertility, and family history.
- Staging involves evaluating tumor size, lymph node involvement, and serum tumor marker levels.
- Treatment depends on cancer type and stage but may include surgery, radiation therapy, platinum-based chemotherapy, and surveillance. Outcomes are generally very good even for metastatic disease.
Testicular tumors
This document discusses testicular tumors, including their etiology, classification, clinical presentation, diagnosis, staging, and treatment. Some key points:
- Testicular cancer is the most common cancer in men ages 15-35 and has a high cure rate with early detection and treatment.
- Risk factors include cryptorchidism, prior testicular cancer, infertility, and genetic factors. Carcinoma in situ is a precursor to most germ cell tumors.
- Tumors are classified as seminomas or non-seminomas. Staging involves tumor markers, imaging, and pathology to determine extent of disease.
- Treatment involves radical orchidectomy followed by radiotherapy for seminomas or chemotherapy for
premanagement of germ cell tumors
The document discusses testicular anatomy and germ cell tumors. It describes the following key points:
1) The testis is the male gonad homologous to the female ovary. The primary lymphatic drainage of the testis is to the retroperitoneal lymph nodes.
2) Germ cell tumors are the most common testicular cancers. They include seminomas and non-seminomas such as embryonal carcinoma, yolk sac tumor, teratoma, and choriocarcinoma.
3) Diagnostic workup involves tumor markers such as AFP, beta-HCG, LDH, and radical inguinal orchiectomy for tissue diagnosis and staging. Biopsy
Testicular tumors
This document provides information on testicular tumors, including their classification, presentation, histopathology, and immunohistochemistry. It discusses the most common types of germ cell tumors - seminoma, spermatocytic seminoma, embryonal carcinoma, yolk sac tumor, and teratoma. It also covers sex cord stromal tumors such as Leydig cell tumor and Sertoli cell tumor. Key points include that seminoma is the most common germ cell tumor in adults. Embryonal carcinoma and yolk sac tumor often occur as components of mixed germ cell tumors. Teratomas contain mature somatic tissues. Immunohistochemistry aids in distinguishing tumor types.
Testicular tumours by dr abrar
This document discusses testicular tumours and their anatomy, etiology, classification, clinical features, diagnosis, staging, and treatment. Some key points:
- Testicular tumours most commonly occur in men ages 20-35 and risk factors include cryptorchidism, Klinefelter syndrome, and history of mumps orchitis.
- Germ cell tumours make up 90-95% of cases and include seminomas, teratomas, embryonal carcinomas, and others. Staging involves clinical exam, imaging, and tumour markers.
- Diagnosis involves ultrasound and biopsy of solid intratesticular masses. Treatment depends on tumour type, stage, and involves surgery, radiation,
Ovariancancer
This document discusses ovarian cancer, including types, staging, risk factors, diagnosis, and treatment. It notes that epithelial ovarian cancer is the most common type and accounts for about 80% of ovarian cancer cases. Staging involves determining if the cancer has spread from the ovaries and involves surgery and chemotherapy as primary treatments. Risk factors include increasing age, family history, and nulliparity. Screening involves physical exam, ultrasound, and tumor markers like CA-125. Surgery to remove as much tumor as possible followed by chemotherapy with carboplatin and paclitaxel is the standard first-line treatment.
Ovarian tumours
This document discusses ovarian masses and cancer of the ovary. It covers the classification, symptoms, diagnosis and management of ovarian tumors. Ovarian masses can be cystic or solid, benign or malignant. The majority are epithelial in origin. Risk factors include early menarche, late menopause, years of ovulation and low parity. Diagnosis involves medical history, physical exam, tumor markers and imaging tests. Treatment consists of surgery along with chemotherapy and/or radiation depending on staging. The prognosis is poor since many cases are diagnosed at late stages.
Prostrate cancer
This document provides information on the anatomy, epidemiology, etiology, pathology, clinical manifestations, staging, diagnosis, Gleason scoring, and treatment of prostate cancer. It describes the prostate as a walnut-sized gland located in front of the rectum and below the bladder. It discusses the risk factors for prostate cancer such as family history and diet. The document outlines the staging system for prostate cancer and lists diagnostic tests including PSA levels, biopsy, and imaging. It also explains Gleason scoring and common treatment options such as surgery, radiation therapy, hormone therapy, and chemotherapy.
Penile cancer
Penile cancer most often develops in uncircumcised men over age 50. 95% are squamous cell carcinoma, developing on the foreskin or penis. Diagnosis involves physical exam, biopsy. Treatment depends on stage but may include surgery, radiation, chemotherapy, or biological therapies to remove cancer and prevent spread. Prognosis is best if caught early before spreading.
Male cancers
The document discusses three types of male cancers: prostate cancer, testicular cancer, and penile cancer. It defines each cancer, discusses their causes, signs and symptoms, methods of treatment, prevention strategies, screening procedures, and programs for prevention in the Philippines. Prostate cancer is the most common male cancer and often has no symptoms in early stages. Testicular cancer is most common in younger men and has high cure rates. Penile cancer risk is higher in uncircumcised men and those with poor hygiene.
Ca Ovary
The document discusses ovarian cancer, including its incidence, risk factors, signs and symptoms, screening and diagnostic methods, staging, types, and treatment options. It notes that ovarian cancer is the fifth most common cancer in women in the US and the most lethal gynecological cancer. Risk factors include age, family history, genetics, reproductive history, and exposure to talcum powder. Screening methods have limitations. Treatment involves surgery, chemotherapy, and sometimes radiotherapy, with prognosis being poor if detected at late stages.
Ovary slide share 2
This document discusses ovarian tumors, specifically germ cell tumors. It provides information on the classification, histopathology, immunoprofile, and other characteristics of various types of ovarian germ cell tumors including dysgerminoma, yolk sac tumor, embryonal carcinoma, choriocarcinoma, immature teratoma, and mature cystic teratoma. It also mentions other rare subtypes such as struma ovarii. The document aims to provide pathology residents with comprehensive information on diagnosing and classifying these tumor types.
Ovarian cancer by oouth unit c medical students o&g
This document provides an overview of ovarian cancer including its epidemiology, risk factors, classification, clinical presentation, diagnosis and treatment. Some key points:
- Ovarian cancer is the most lethal gynecologic malignancy and the 2nd most common cancer of the female genital tract. Worldwide over 140,000 new cases are diagnosed annually.
- Risk increases with age, with the average age of diagnosis being 64 years. Genetic factors contribute to about 5-10% of cases.
- Tumors can arise from the epithelial covering, sex cord-stroma or germ cells. The commonest are epithelial tumors including serous, mucinous, endometrioid and clear cell sub
Testicular tumour/ case history
1. Testicular neoplasm is a rare malignancy that affects men aged 20-40 years old. It presents most commonly as a painless testicular mass.
2. Diagnostic workup includes physical exam, tumor markers, imaging, and biopsy. Seminomas and nonseminomas are the two main types and have different characteristics and treatment approaches.
3. Treatment depends on stage but may include surgery, chemotherapy, and radiation. The prognosis is generally good even for advanced or relapsed disease.
Ovariancancer chandni
The document discusses risk factors, diagnosis, staging, pathology, and management of ovarian cancer. It notes that family history and nulliparity are strong risk factors. Diagnosis involves physical exam, tumor markers like CA125, ultrasound, and CT or MRI imaging. Staging follows FIGO guidelines from I to IV based on extent of spread. Ovarian cancer typically spreads via direct extension or through the peritoneal cavity. Treatment involves surgical staging and tumor debulking followed by chemotherapy, while radiation plays a limited role.
Ovarian cancer
Ovarian cancer is the seventh most common cancer in women worldwide. It has a high mortality rate due to over 75% of cases being diagnosed at late stages when the cancer has spread. The major risk factors include genetic mutations, such as BRCA1 and BRCA2, as well as reproductive factors like fewer pregnancies. The main types are epithelial ovarian carcinomas, which make up 90% of ovarian cancer cases. Screening tools include transvaginal ultrasounds, CA125 testing, and the OVA1 test, but early detection remains a challenge due to asymptomatic nature in early stages. Research is ongoing into novel therapies and molecular targets for the different subtypes of this cancer.
Testicular Cancer
This document provides information on testicular cancer, including its incidence, histology, lymph node drainage patterns, staging classifications, workup, and management guidelines. Some key points:
- Testicular cancers constitute 1% of all cancers and germ cell tumors are the most common solid tumors in men aged 15-35.
- Lymph node drainage patterns differ for right and left testes, with retroperitoneal lymph nodes being the most common site of spread.
- Germ cell tumors are the most common type and are classified based on their histologic components.
- Staging involves the TNM classification and serum tumor marker levels. Workup includes imaging, tumor marker tests, and radical orchi
Testicular tumors
This document provides a detailed overview of testicular cancer classifications, histology, screening tools, management approaches, and prognostic factors. It discusses the various histologic types of germ cell tumors and sex cord-gonadal stromal tumors. For each type, it describes characteristics such as common age range, histologic features, tumor markers, and treatment approaches. It also summarizes staging evaluations and the role of imaging, tumor markers, surgery, radiation therapy, chemotherapy, and surveillance in testicular cancer management.
More Related Content
What's hot
Testicular cancer
The document discusses testicular cancer and provides details on its epidemiology, classification, staging, diagnosis, and disease management. Some key points:
- Testicular cancer peaks in the third decade for non-seminoma and fourth decade for seminoma. Risk factors include cryptorchidism, family history, and subfertility.
- Germ cell tumors are divided into seminoma and non-seminomatous tumors including embryonal carcinoma, teratoma, and choriocarcinoma.
- Stage I disease accounts for 75-80% of seminoma and 55% of non-seminoma cases at diagnosis. Serum tumor markers and imaging help determine diagnosis and staging.
Testicular carcinoma
This document provides a summary of testicular carcinoma and germ cell tumors. It discusses the classification, spread, clinical features, investigations, and staging of testicular tumors. The majority are germ cell tumors, with seminomas and non-seminomatous germ cell tumors being the most common. Metastatic sites vary between seminomas and non-seminomas. Prognostic factors are important for determining treatment. Screening is recommended for high risk groups to detect tumors early.
Testicular tumors - ramu
This document discusses testicular tumors. It notes that testicular cancer is rare but the most common solid malignancy in young men aged 15-35. The main types of testicular tumors are germ cell tumors (such as seminoma, embryonal carcinoma, teratoma, and choriocarcinoma) and non-germ cell tumors. Risk factors include cryptorchidism, family history, and testicular cancer history. Diagnostic tests include scrotal ultrasound and serum tumor markers. Radical inguinal orchiectomy is the standard treatment for removal of the testis.
Carcinoma penis
This document discusses carcinomas and precancerous conditions of the penis. It describes several precancerous conditions that have potential to develop into penile cancer, including penile intraepithelial neoplasia, balanitis xerotica obliterans, and Buschke-Lowenstein tumour. Squamous cell carcinoma is the most common type of penile cancer. Risk factors include age, pre-existing lesions, lack of circumcision, HPV infection, and smoking. Treatment involves surgery for the primary tumor as well as lymphadenectomy for lymph node involvement.
Testicular cancer
This document discusses testicular cancer, including:
- 95% of testicular cancers are germ cell tumors known as seminomas or non-seminomas.
- Risk factors include undescended testes, male infertility, and family history.
- Staging involves evaluating tumor size, lymph node involvement, and serum tumor marker levels.
- Treatment depends on cancer type and stage but may include surgery, radiation therapy, platinum-based chemotherapy, and surveillance. Outcomes are generally very good even for metastatic disease.
Testicular tumors
This document discusses testicular tumors, including their etiology, classification, clinical presentation, diagnosis, staging, and treatment. Some key points:
- Testicular cancer is the most common cancer in men ages 15-35 and has a high cure rate with early detection and treatment.
- Risk factors include cryptorchidism, prior testicular cancer, infertility, and genetic factors. Carcinoma in situ is a precursor to most germ cell tumors.
- Tumors are classified as seminomas or non-seminomas. Staging involves tumor markers, imaging, and pathology to determine extent of disease.
- Treatment involves radical orchidectomy followed by radiotherapy for seminomas or chemotherapy for
premanagement of germ cell tumors
The document discusses testicular anatomy and germ cell tumors. It describes the following key points:
1) The testis is the male gonad homologous to the female ovary. The primary lymphatic drainage of the testis is to the retroperitoneal lymph nodes.
2) Germ cell tumors are the most common testicular cancers. They include seminomas and non-seminomas such as embryonal carcinoma, yolk sac tumor, teratoma, and choriocarcinoma.
3) Diagnostic workup involves tumor markers such as AFP, beta-HCG, LDH, and radical inguinal orchiectomy for tissue diagnosis and staging. Biopsy
Testicular tumors
This document provides information on testicular tumors, including their classification, presentation, histopathology, and immunohistochemistry. It discusses the most common types of germ cell tumors - seminoma, spermatocytic seminoma, embryonal carcinoma, yolk sac tumor, and teratoma. It also covers sex cord stromal tumors such as Leydig cell tumor and Sertoli cell tumor. Key points include that seminoma is the most common germ cell tumor in adults. Embryonal carcinoma and yolk sac tumor often occur as components of mixed germ cell tumors. Teratomas contain mature somatic tissues. Immunohistochemistry aids in distinguishing tumor types.
Testicular tumours by dr abrar
This document discusses testicular tumours and their anatomy, etiology, classification, clinical features, diagnosis, staging, and treatment. Some key points:
- Testicular tumours most commonly occur in men ages 20-35 and risk factors include cryptorchidism, Klinefelter syndrome, and history of mumps orchitis.
- Germ cell tumours make up 90-95% of cases and include seminomas, teratomas, embryonal carcinomas, and others. Staging involves clinical exam, imaging, and tumour markers.
- Diagnosis involves ultrasound and biopsy of solid intratesticular masses. Treatment depends on tumour type, stage, and involves surgery, radiation,
Ovariancancer
This document discusses ovarian cancer, including types, staging, risk factors, diagnosis, and treatment. It notes that epithelial ovarian cancer is the most common type and accounts for about 80% of ovarian cancer cases. Staging involves determining if the cancer has spread from the ovaries and involves surgery and chemotherapy as primary treatments. Risk factors include increasing age, family history, and nulliparity. Screening involves physical exam, ultrasound, and tumor markers like CA-125. Surgery to remove as much tumor as possible followed by chemotherapy with carboplatin and paclitaxel is the standard first-line treatment.
Ovarian tumours
This document discusses ovarian masses and cancer of the ovary. It covers the classification, symptoms, diagnosis and management of ovarian tumors. Ovarian masses can be cystic or solid, benign or malignant. The majority are epithelial in origin. Risk factors include early menarche, late menopause, years of ovulation and low parity. Diagnosis involves medical history, physical exam, tumor markers and imaging tests. Treatment consists of surgery along with chemotherapy and/or radiation depending on staging. The prognosis is poor since many cases are diagnosed at late stages.
Prostrate cancer
This document provides information on the anatomy, epidemiology, etiology, pathology, clinical manifestations, staging, diagnosis, Gleason scoring, and treatment of prostate cancer. It describes the prostate as a walnut-sized gland located in front of the rectum and below the bladder. It discusses the risk factors for prostate cancer such as family history and diet. The document outlines the staging system for prostate cancer and lists diagnostic tests including PSA levels, biopsy, and imaging. It also explains Gleason scoring and common treatment options such as surgery, radiation therapy, hormone therapy, and chemotherapy.
Penile cancer
Penile cancer most often develops in uncircumcised men over age 50. 95% are squamous cell carcinoma, developing on the foreskin or penis. Diagnosis involves physical exam, biopsy. Treatment depends on stage but may include surgery, radiation, chemotherapy, or biological therapies to remove cancer and prevent spread. Prognosis is best if caught early before spreading.
Male cancers
The document discusses three types of male cancers: prostate cancer, testicular cancer, and penile cancer. It defines each cancer, discusses their causes, signs and symptoms, methods of treatment, prevention strategies, screening procedures, and programs for prevention in the Philippines. Prostate cancer is the most common male cancer and often has no symptoms in early stages. Testicular cancer is most common in younger men and has high cure rates. Penile cancer risk is higher in uncircumcised men and those with poor hygiene.
Ca Ovary
The document discusses ovarian cancer, including its incidence, risk factors, signs and symptoms, screening and diagnostic methods, staging, types, and treatment options. It notes that ovarian cancer is the fifth most common cancer in women in the US and the most lethal gynecological cancer. Risk factors include age, family history, genetics, reproductive history, and exposure to talcum powder. Screening methods have limitations. Treatment involves surgery, chemotherapy, and sometimes radiotherapy, with prognosis being poor if detected at late stages.
Ovary slide share 2
This document discusses ovarian tumors, specifically germ cell tumors. It provides information on the classification, histopathology, immunoprofile, and other characteristics of various types of ovarian germ cell tumors including dysgerminoma, yolk sac tumor, embryonal carcinoma, choriocarcinoma, immature teratoma, and mature cystic teratoma. It also mentions other rare subtypes such as struma ovarii. The document aims to provide pathology residents with comprehensive information on diagnosing and classifying these tumor types.
Ovarian cancer by oouth unit c medical students o&g
This document provides an overview of ovarian cancer including its epidemiology, risk factors, classification, clinical presentation, diagnosis and treatment. Some key points:
- Ovarian cancer is the most lethal gynecologic malignancy and the 2nd most common cancer of the female genital tract. Worldwide over 140,000 new cases are diagnosed annually.
- Risk increases with age, with the average age of diagnosis being 64 years. Genetic factors contribute to about 5-10% of cases.
- Tumors can arise from the epithelial covering, sex cord-stroma or germ cells. The commonest are epithelial tumors including serous, mucinous, endometrioid and clear cell sub
Testicular tumour/ case history
1. Testicular neoplasm is a rare malignancy that affects men aged 20-40 years old. It presents most commonly as a painless testicular mass.
2. Diagnostic workup includes physical exam, tumor markers, imaging, and biopsy. Seminomas and nonseminomas are the two main types and have different characteristics and treatment approaches.
3. Treatment depends on stage but may include surgery, chemotherapy, and radiation. The prognosis is generally good even for advanced or relapsed disease.
Ovariancancer chandni
The document discusses risk factors, diagnosis, staging, pathology, and management of ovarian cancer. It notes that family history and nulliparity are strong risk factors. Diagnosis involves physical exam, tumor markers like CA125, ultrasound, and CT or MRI imaging. Staging follows FIGO guidelines from I to IV based on extent of spread. Ovarian cancer typically spreads via direct extension or through the peritoneal cavity. Treatment involves surgical staging and tumor debulking followed by chemotherapy, while radiation plays a limited role.
Ovarian cancer
Ovarian cancer is the seventh most common cancer in women worldwide. It has a high mortality rate due to over 75% of cases being diagnosed at late stages when the cancer has spread. The major risk factors include genetic mutations, such as BRCA1 and BRCA2, as well as reproductive factors like fewer pregnancies. The main types are epithelial ovarian carcinomas, which make up 90% of ovarian cancer cases. Screening tools include transvaginal ultrasounds, CA125 testing, and the OVA1 test, but early detection remains a challenge due to asymptomatic nature in early stages. Research is ongoing into novel therapies and molecular targets for the different subtypes of this cancer.
What's hot (20)
Ovarian cancer by oouth unit c medical students o&g
Ovarian cancer by oouth unit c medical students o&g
Viewers also liked
Testicular Cancer
This document provides information on testicular cancer, including its incidence, histology, lymph node drainage patterns, staging classifications, workup, and management guidelines. Some key points:
- Testicular cancers constitute 1% of all cancers and germ cell tumors are the most common solid tumors in men aged 15-35.
- Lymph node drainage patterns differ for right and left testes, with retroperitoneal lymph nodes being the most common site of spread.
- Germ cell tumors are the most common type and are classified based on their histologic components.
- Staging involves the TNM classification and serum tumor marker levels. Workup includes imaging, tumor marker tests, and radical orchi
Testicular tumors
This document provides a detailed overview of testicular cancer classifications, histology, screening tools, management approaches, and prognostic factors. It discusses the various histologic types of germ cell tumors and sex cord-gonadal stromal tumors. For each type, it describes characteristics such as common age range, histologic features, tumor markers, and treatment approaches. It also summarizes staging evaluations and the role of imaging, tumor markers, surgery, radiation therapy, chemotherapy, and surveillance in testicular cancer management.
Testicular cancer
Testicular cancer, or cancer of the testes, occurs in the testicles (testes), inside the scrotum. The scrotum is a loose bag of skin under the penis. Male sex hormones, testosterone, and sperm for reproduction are produced in the testicles. The testicles are a pair of male sex glands, also known as gonads.
Testosterone controls the development of the reproductive organs, and other male physical characteristics.
BPH, Prostate Cancer, Testicular Cancer
The document summarizes benign prostatic hyperplasia (BPH), testicular cancer, and prostate cancer. It describes the etiology, epidemiology, pathophysiology, risk factors, signs and symptoms, diagnostic workup, and treatment for each condition. It compares the pathophysiology, clinical presentation, diagnostic workup and treatment of BPH and prostate cancer. BPH and prostate cancer are both common prostate disorders in aging men, but have different causes, presentations and treatments. Testicular cancer most often appears as a painless testicular mass in younger men and requires orchiectomy for diagnosis and treatment.
Testicular tumours
This document provides information on testicular tumors, including their epidemiology, risk factors, classification, types, clinical features, investigations, staging, and spread. Some key points:
- Testicular tumors comprise 1-2% of all malignancies and 95% are germ cell tumors (GCTs), which predominantly affect young males.
- Risk factors include cryptorchidism, family history, prior testicular cancer, intratubular germ cell neoplasia, and environmental exposures.
- The main types of GCTs are seminoma, embryonal carcinoma, choriocarcinoma, yolk sac tumor, and teratoma.
- Clinical features depend on whether the
TESTICULAR CANCERS
testicular cancer:anatomy of testis
epidemiology,risk factors and spread of testicular cancer
clinical presentation
tumor markers AFP,BHCG,LDH
Viewers also liked (6)
Similar to All About Testicular Cancer
Ovarian cancer abbey
Ovarian cancer forms in the ovaries and there are several types, with epithelial carcinoma being the most common at 90%. It can be hereditary when there is a genetic mutation to the BRCA1 or BRCA2 genes. While hereditary, ovarian cancer can also be caused by environmental factors like infertility, hormone replacement or estrogen therapy, obesity, and talcum powder use. Symptoms are usually vague and include abdominal bloating or pain, changes in digestion or urination, but treatment options include surgery, chemotherapy, radiation, and immunotherapy. Prevention focuses on lifestyle changes and avoiding known risk factors.
Prevention of cancer in women
This document discusses prevention of breast and cervical cancer in women. It covers leading causes of death for women, risk factors, screening methods, symptoms, and preventive measures. The key points are:
1) Heart disease, cancer, and stroke are the top three leading causes of death for women. Cancer screening and treatments have improved survival rates to 66% for people diagnosed between 1966-2002.
2) Risk factors for cancer include age, family history, lifestyle factors like smoking, and genetic conditions. Screening methods include self-exams, clinical exams, mammography, and HPV testing to detect cancers early.
3) Preventive measures include vaccinations, safe sexual practices, smoking cessation, healthy
Ovarian Cancer: Symptoms, Diagnosis and BRCA Testing for High Risk Individuals
Ovarian Cancer: Symptoms, Diagnosis and BRCA Testing for High Risk IndividualsSibley Memorial Hospital
Sibley Memorial Hospital's Knowledge is Power lecture series on Ovarian Health. Presented by Marilyn Jerome Foust, M.D., on September 13, 2012.Us2aware
The document discusses prostate cancer facts that men over 40 should know. It explains that prostate cancer is the most common non-skin cancer in American men and the second leading cause of cancer death. While symptoms may not always be present, early detection through annual PSA tests and digital rectal exams starting at age 40 or age 45 for those with risk factors can help find prostate cancer early and increase chances of survival. The document provides information on risk factors like age, race, family history and diet to help men understand their risk and need for screening.
Cervical cancer
Cervical cancer is a major health problem, especially in developing countries like India. It is caused by certain strains of the human papillomavirus (HPV). Regular Pap screening can detect precancerous cell changes early when treatment is most effective. The HPV vaccine, when administered before sexual debut, can prevent HPV infection and thus most cervical cancers. Together, vaccination and screening can end cervical cancer as a major public health problem.
Cancer awareness
Dr. Sowjanya Kurakula discusses various cancers that commonly affect women. Breast cancer is the most common cancer among women globally, accounting for 1 in 3 cancers. Cervical cancer remains a major cause of cancer death in developing countries where Pap screening is not available. The human papillomavirus vaccine protects against HPV, which causes cervical cancer. Screening through Pap tests and HPV testing enables early detection and treatment of cervical and other cancers. Lifestyle factors like diet, exercise, and avoiding tobacco can help reduce cancer risks.
USToo: About Prostate Cancer
This document provides information about prostate cancer including:
1) It discusses what the prostate gland is and risk factors for prostate cancer such as age, family history, diet, and race. African American men and those with a family history have a higher risk.
2) Early detection through annual PSA tests and digital rectal exams starting at age 40 is key, as having cancer detected early dramatically improves survival rates.
3) It recommends seeing a doctor annually for PSA tests and rectal exams to screen for prostate cancer and catch it as early as possible to improve treatment options. Knowing individual PSA levels allows men to monitor their prostate health over time.
Cervical Cancer 101
Cervical cancer is caused by persistent HPV infection in the cervix. HPV is very common and spread through skin to skin genital contact. While most HPV infections go away on their own, persistent infections can lead to cervical cancer if not addressed. Regular Pap screening can detect pre-cancerous cells early so they can be treated before they develop into cancer. Prevention strategies include HPV vaccination, smoking cessation, condom use, and limiting sexual partners. Abnormal Pap results may require further tests like colposcopy or biopsies. Early cervical cancer is highly curable, especially when caught through regular screening.
Oncology Nursing Lecture
The document provides 10 true or false questions about cancer followed by topics for discussion on cancer including comparing normal and cancer cells, differentiating between benign and malignant tumors, and describing standard cancer treatments like surgery, radiation, and chemotherapy. Nursing care for cancer patients is also addressed, covering topics like skin integrity, nutrition, body image, and complications of cancer treatment.
ROJoson PEP Talk: Cancer Awareness and Myths on Causation
There are several common myths about the causes of cancer that are not supported by scientific evidence:
- Cancer is not always genetic, as only 5-10% of cancers are hereditary while the majority are caused by environmental and lifestyle factors.
- A family history of cancer does not necessarily mean someone will get cancer, as most familial cancers are due to shared environmental exposures rather than inherited genetics.
- Most everyday items like cell phones, microwaved plastics, hair dyes and underwire bras have not been shown to cause cancer.
- Emotional states like stress and trauma, as well as foods like sugar, have not been found to directly cause or worsen existing cancers. While diet
Cancer genetics
Genetic testing and counseling can help determine cancer risk based on family history and genetic mutations. Most cancers are sporadic but 5-10% are hereditary due to inherited gene mutations. Genetic counselors use family histories and genetic tests to assess cancer risks, recommend screening, and provide counseling to relatives. While some cancers have clear high-risk genes, most have contributions from multiple common and rare variants, so interpretation requires expertise.
Ca cervix REVISED FIGO STAGING
This document discusses cervical cancer, the most common gynecological cancer in India. It notes that cervical cancer is caused by persistent human papillomavirus (HPV) infection and has known risk factors. Screening through tests like Pap smear and HPV testing can detect pre-cancerous lesions so that treatment can prevent progression to invasive cancer. The document outlines HPV types that cause cervical cancer, the role of HPV vaccines, and diagnostic tools for cervical cancer screening and diagnosis like VIA, VILI, colposcopy, and biopsy.
Cervical Cancer by Roel Tolentino
This lecture is about cervical cancer or cancer of the cervix. This malignancy is very common among women in the Philippines. Treatments may consist of radiation, surgery, chemotherapy or a combination modality. Prevention may be achieved by vaccination.
screening_and_prevention protocols for_cervix.ppt
This document discusses cervical cancer, its causes, prevention, and screening. Some key points:
- Cervical cancer is a major problem in India, with over 200 women dying from it daily.
- HPV infection is the main cause, with types 16 and 18 responsible for over 75% of cases.
- Screening through Pap smears and HPV testing can detect pre-cancerous lesions early and prevent cervical cancer by treating these lesions.
- Other prevention methods include the HPV vaccine.
- Colposcopy is used to examine the cervix in more detail if abnormal cells are found on screening.
Pgp ovarain case
- Ovarian cancer is the seventh most common cancer in women in the United States and the fifth most common cause of cancer death in women. It contributes to around 5.9% of total cancer cases in India.
- Risk factors include family history, particularly mutations in BRCA1 and BRCA2 genes, ethnicity, nulliparity, infertility, early menarche and late menopause. Protective factors include multiparity, oral contraceptive use, prophylactic oophorectomy and tubal ligation.
- Ovarian cancers are classified as epithelial, sex cord-stromal, germ cell tumors or secondary metastases from other sites like breast or gastrointestinal tract. The most common type is high
Cancer
Cancer can be caused by environmental hazards like carcinogens in air, water, and soil from industrial sources and lifestyle factors. Smoking increases the risk of several cancers like lung cancer through exposure of tissues to smoke. Radiation and some food additives are also known to increase cancer risk. Genetic factors play a role, though most cancers are not caused by inherited genes. Symptom awareness and seeking prompt treatment are important for cancer management, as some symptoms like lumps, persistent coughs, or abnormal bleeding could indicate cancer.
Hereditary Cancer Syndrome
This document summarizes hereditary cancer syndromes and BRCA mutations. It discusses that most cancers are sporadic, but 5-10% are hereditary due to germline mutations passed down from relatives. Hereditary cancers often occur earlier and increase risk for multiple cancer types. Specific cancer susceptibility genes are discussed, including BRCA1 and BRCA2 mutations which increase lifetime risks of breast and ovarian cancers. Diagnostic testing and management strategies for individuals with BRCA mutations are outlined, including increased cancer screening, risk-reducing surgeries, and lifestyle modifications. Genetic counseling plays an important role in assessing cancer risks and managing hereditary cancer syndromes in families.
Breast
The document summarizes information about using mice as a model for studying breast development and breast cancer research. It discusses breast cancer statistics and risk factors in humans. It then describes the anatomy and histology of the human and mouse mammary glands, explaining why mice are a useful model. Some key reasons mentioned are that mouse and human breast tissue are comparable histologically and mice allow for genetic manipulation of the mammary glands. The document also outlines several approaches for inducing mammary tumors in mice, such as through chemical carcinogens, transgenic overexpression of oncogenes, or knockout of tumor suppressor genes. Finally, it briefly discusses human breast pathology and factors that predict breast cancer treatment outcomes.
Common gynaecological carcinom final2
Gestational trophoblastic disease includes complete and partial hydatidiform moles, invasive moles, choriocarcinoma, and placental site trophoblastic tumors, with molar pregnancies requiring surgical evacuation and strict follow up of beta HCG levels to monitor for malignant transformation into gestational trophoblastic neoplasia. Risk factors include extremes of maternal age, previous molar pregnancies, and ethnicity, while presentation is typically irregular bleeding and an enlarged uterus out of proportion to gestational age.
HPV vaccination importance in Lesotho
This document discusses cervical cancer prevention strategies in Lesotho. It provides an overview of international conventions on cervical cancer and Lesotho's response. Key points include high rates of cervical cancer in Lesotho compared to other Southern African countries. Prevention strategies discussed include HPV vaccination, screening programs like VIA and Pap smears, and education initiatives targeting policymakers, health workers, and communities. Human papillomavirus (HPV) is identified as the cause of most cervical cancer cases worldwide.
Similar to All About Testicular Cancer (20)
Ovarian Cancer: Symptoms, Diagnosis and BRCA Testing for High Risk Individuals
Ovarian Cancer: Symptoms, Diagnosis and BRCA Testing for High Risk Individuals
ROJoson PEP Talk: Cancer Awareness and Myths on Causation
ROJoson PEP Talk: Cancer Awareness and Myths on Causation
Recently uploaded
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...chandankumarsmartiso
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun Women Seeking Service
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations Recently uploaded (20)
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
All About Testicular Cancer
- 1. ALL ABOUT TESTICULAR CANCER PRESENTED BY BTB SUNGLASSES in Conjunction with the Testicular Cancer Society
- 2. WHOGETSIT AGE Most commonly found in men ages 15-35 years old
- 3. WHOGETSIT Diagnosis per 100,000 men by race/ethnicity 6 12 4 White African Pacific Hispanic American Islander
- 4. SURVIVALRATES 99 % 96 % 72 % 85 % Cancer Cancer Cancer Cancer Localized Regionalized Metastasized Unstaged at primary site spread to spread distantly at unknown lymphnodes stage
- 5. SURVIVALRATES 390 Men Die R.I.P. Annually from 21 Testicular Cancer. That’s more than 1 DEATH Monday PER DAY November 2011
- 6. OCCUPATIONAL HAZARD Occupations with a Higher Risk Miners Food Utility Leather Processing Workers Workers Workers
- 7. RISKFACTORS Marijuana use makes you 70 % more likely to develop testicular cancer Marijuana may also be linked to an aggressive testicular cancer that grows very quickly. Family History TC Having a brother or father who had TC testicular cancer increases your risk
- 8. THE SYMPTOMS See a physician if any of the following symptoms lasts two weeks or longer 2. Dull ache or sharp pain 1. Lump in either testicle in testicle or scrotum 4. Feeling of heaviness in the scrotum 5. Collection of fluid in the scrotum 3. Enlargement of a testicle
- 9. NO-SHA NOVEMBER VE TCAWARENESS MONTH
- 10. SOURCES http://facstaff.unca.edu/cnicolay/BIO108/HO-Testicular%20Cancer.pdf http://www.ohsu.edu/xd/health/services/cancer/getting-treatment/services/testicular-cancer.cfm http://www.fhcrc.org/about/ne/news/2009/02/09/marijuana.html http://www.fhcrc.org/about/ne/news/2009/02/09/marijuana.html http://urology.ucla.edu/body.cfm?id=157 http://www.rwjuh.edu/health_information/adult_men_testicu.html http://www.askmen.com/sports/health_400/412_testicular-cancer-myths.html http://www.askmen.com/sports/health_400/412_testicular-cancer-myths.html http://www.askmen.com/sports/health_400/412_testicular-cancer-myths.html http://www.med.wayne.edu/urology/DISEASES/testicularcancer.html PRESENTED BY BTB SUNGLASSES in Conjunction with the Testicular Cancer Society